https://www.selleckchem.com/pr....oducts/a-1331852.htm
e diagnosis and monitoring of NEC. Trial Registry ClinicalTrials.gov; ChiCTR-ROC-17013746; URL www.clinicaltrials.gov. Copyright © 2020 Fu, Li, Yang, She, Ai and Wang.Reactivation of latent cytomegalovirus (CMV) in recipients of hematopoietic cell transplantation (HCT) not only results in severe organ manifestations, but can also cause "graft failure" resulting in bone marrow (BM) aplasia. This inhibition of hematopoietic stem and progenitor cell engraftment is a manifestation of CMV infection that is long known in clinical hematology
Like
Comment
Share
